110 related articles for article (PubMed ID: 15028243)
21. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
[TBL] [Abstract][Full Text] [Related]
22. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.
Saura J; Kettler R; Da Prada M; Richards JG
J Neurosci; 1992 May; 12(5):1977-99. PubMed ID: 1578281
[TBL] [Abstract][Full Text] [Related]
23. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
[TBL] [Abstract][Full Text] [Related]
24. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition.
Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Wolf AP; Warner D; Cilento R; Zezulkova I
J Addict Dis; 1998; 17(1):23-34. PubMed ID: 9549600
[TBL] [Abstract][Full Text] [Related]
25. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of radioiodinated iodoclorgyline as a SPECT radiopharmaceutical for MAO-A in the brain.
Hirata M; Magata Y; Ohmomo Y; Saji H; Murakami K; Takagaki T; Yamamura N; Tanaka C; Konishi J; Yokoyama A
Nucl Med Biol; 1995 Feb; 22(2):175-80. PubMed ID: 7767310
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of monoamine oxidase A and B type enzyme occupancy using non-radiolabelled tracers in rat brain.
Thentu JB; Bhyrapuneni G; Padala NP; Chunduru P; Pantangi HR; Nirogi R
Neurochem Int; 2021 May; 145():105006. PubMed ID: 33636211
[TBL] [Abstract][Full Text] [Related]
29. Monoamine oxidase in bovine thyroid tissue.
Masini-Repiso AM; Cabanillas AM; Andrada MC; Coleoni AH
Horm Metab Res; 1986 Nov; 18(11):750-3. PubMed ID: 3098663
[TBL] [Abstract][Full Text] [Related]
30. Development of new radiopharmaceuticals for imaging monoamine oxidase B.
Vasdev N; Sadovski O; Moran MD; Parkes J; Meyer JH; Houle S; Wilson AA
Nucl Med Biol; 2011 Oct; 38(7):933-43. PubMed ID: 21982565
[TBL] [Abstract][Full Text] [Related]
31. Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.
Arnett CD; Fowler JS; MacGregor RR; Schlyer DJ; Wolf AP; Långström B; Halldin C
J Neurochem; 1987 Aug; 49(2):522-7. PubMed ID: 3110375
[TBL] [Abstract][Full Text] [Related]
32. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
[TBL] [Abstract][Full Text] [Related]
33. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of 11C-labeled fluoroclorgyline: a monoamine oxidase A specific inhibitor for positron emission tomography.
Ohmomo Y; Hirata M; Murakami K; Magata Y; Tanaka C; Yokoyama A
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1994-7. PubMed ID: 8293522
[TBL] [Abstract][Full Text] [Related]
35. In vitro-in vivo correlation for intrinsic clearance for CP-409,092 and sumatriptan: a case study to predict the in vivo clearance for compounds metabolized by monoamine oxidase.
Kamel A; Colizza K; Gunduz M; Harriman S; Obach RS
Xenobiotica; 2012 Apr; 42(4):355-62. PubMed ID: 22106962
[TBL] [Abstract][Full Text] [Related]
36. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
37. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
Guang HM; Du GH
Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
[TBL] [Abstract][Full Text] [Related]
38. Titration of human brain monoamine oxidase -A and -B by clorgyline and L-deprenil.
Fowler CJ; Oreland L; Marcusson J; Winblad B
Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):263-72. PubMed ID: 6771658
[TBL] [Abstract][Full Text] [Related]
39. Monoamine oxidase activity in rat and human odontoblasts: a microgasometric study.
Pavlin R; Kosir N; Vidmar V
J Oral Pathol Med; 1991 Apr; 20(4):200. PubMed ID: 1905757
[TBL] [Abstract][Full Text] [Related]
40. Translational neuroimaging: positron emission tomography studies of monoamine oxidase.
Fowler JS; Logan J; Volkow ND; Wang GJ
Mol Imaging Biol; 2005; 7(6):377-87. PubMed ID: 16265597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
